ArticleThe British journal of dermatology2021

Long-term safety of certolizumab pegol in plaque psoriasis: pooled analysis over 3 years from three phase III, randomized, placebo-controlled studies.

A Blauvelt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.